APA (7th ed.) Citation

G, I., M, Z., R, A., SF, A., A, A., S, K., . . . B, Y. (2026). The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 23(2), e00861. https://doi.org/10.1016/j.neurot.2026.e00861

Chicago Style (17th ed.) Citation

G, Ismail, et al. "The Real-world Effectiveness and Safety of Off-label Rituximab in a Large Cohort of Middle Eastern Multiple Sclerosis Patients." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 23, no. 2 (2026): e00861. https://doi.org/10.1016/j.neurot.2026.e00861.

MLA (9th ed.) Citation

G, Ismail, et al. "The Real-world Effectiveness and Safety of Off-label Rituximab in a Large Cohort of Middle Eastern Multiple Sclerosis Patients." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, vol. 23, no. 2, 2026, p. e00861, https://doi.org/10.1016/j.neurot.2026.e00861.